Suspected Recurrence of Symptomatic COVID-19: Management During Inpatient Psychiatric Treatment.
J Psychiatr Pract
; 27(2): 137-144, 2021 Mar 05.
Article
in English
| MEDLINE | ID: covidwho-1292182
ABSTRACT
The widespread prevalence of coronavirus disease 2019 (COVID-19) means that inpatient psychiatric units will necessarily manage patients who have COVID-19 that is comorbid with acute psychiatric symptoms. We report a case of recurrence of respiratory symptoms and positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) testing in a patient on an inpatient psychiatric unit occurring 42 days after the initial positive SARS-CoV-2 RT-PCR test, 38 days after initial symptom resolution, and 30 days after the first of 3 negative SARS-CoV-2 RT-PCR tests. Over the course of the admission, the patient was safely initiated on clozapine. Recent literature on COVID-19's potential recurrence and neuropsychiatric effects is reviewed and implications for the management of COVID-19 on inpatient psychiatric units are discussed. In the era of COVID-19 and our still-developing understanding of this illness, psychiatrists' role as advocates and collaborators in our patients' physical health care has become even more critical.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Psychotic Disorders
/
Antipsychotic Agents
/
Depressive Disorder, Major
/
COVID-19
/
Antidepressive Agents
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
/
Qualitative research
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
J Psychiatr Pract
Journal subject:
Psychiatry
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS